💥 #PhDposition available💥
We're pleased to announce an additional call for applications for the DC6-Brain mosaicism affecting the #mTOR pathway (@BaulacS lab at @ParisBrainInst ). Apply here by June 26 : https://t.co/JaLe3Stuec
Starting date : September 1
🕰️The MENTOR PhD Recruitment Call is Now Closed!
🙏A huge thank you to everyone who showed interest in our program and to all the candidates who applied over the past two months! We were thrilled to receive so many applications from talented researchers worldwide.
🚨 PhD Opportunity Alert! 🚨
Join @KU_Leuven for an exciting #PhD position on mTOR modulation in kidney #mTORopathies! 🔬✨
✅ Fully funded by #MSCA
✅ Collaborate with top institutions across Europe
✅ €3400/month + mobility & family allowances
🌍 Secondments at @PD_value (drug response modeling) 🇳🇱 & @InstitutCerveau (DNA sequencing) 🇫🇷 📅 Start: July–Sept 2025
Apply by March 28, 2025 & contribute to cutting-edge epilepsy research!
➡️More info & apply: https://t.co/nwhSjzLRRx
#PhD#mTOR#EpilepsyResearch#Neurology
🚨 PhD Opportunity – Metabolism & mTORopathies! 🚨
🧠 DC 17 – PhD in Medicine
🔬 Investigate metabolic markers in mTOR-related epilepsy
📍 @UMCU_Intl, Netherlands 🇳🇱
💰 €3,726.4/month + allowances
🎓 Fully funded PhD in Neurology & Metabolic Research
🌍 Secondments at #UniversityofTübingen 🇩🇪, @UniversityofBasel🇨🇭 & @InstitutCerveau 🇫🇷
📅 Start: July–Sept 2025
📢 Apply by March 28, 2025 & contribute to cutting-edge drug modeling research!
🚨 PhD Opportunity – PROTACs & mTORopathies! 🚨
🧪 DC 15 – PhD in Drug Discovery
🔬 Develop S6K1- & S6K2-selective PROTAC degraders
📍 University of Tübingen, Germany 🇩🇪
💰 €3,342.4/month + allowances
🎓 Fully funded PhD in Pharmacy
🚨 Final Reminder – 1 Week Left to Apply! 🚨
Time is running out! ⏳ There’s only one week left until the application deadline for the MENTOR PhD Program.
📅 Deadline: March 28, 2025
🔬 Fully funded PhD positions in cutting-edge research
🌍 International secondments
🚨 PhD Opportunity – Medicinal Chemistry & mTORopathies! 🚨
🧪 DC 14 – PhD in Drug Discovery
🔬 Optimize S6K2-selective inhibitors for in vivo application
📍 University of Tübingen, Germany 🇩🇪
💰 €3,342.4/month + allowances
🎓 Fully funded PhD in Pharmacy